This content is intended for UK & ROI healthcare professionals. Not a healthcare professional? Return to audience selector.

In this expert video series, Dr Abbas Khushnood, Consultant Paediatric Cardiologist and Transplant Physician, who formerly worked in the Freeman Hospital in Newcastle, UK, shares real world insights into the evolving management of paediatric heart failure with Aqumeldi®.

This content reflects expert opinion. Certain elements are based on professional judgment and personal interpretation informed by clinical experience and expertise.

Expert Experience with Aqumeldi®

Can you tell us about your experience using Aqumeldi®

in your paediatric heart failure patients?

Introduction to LENA Study

Thinking about your introduction to Aqumeldi® and the LENA studies, what specific data has stood out to you as a clinician and why?

Prescribing and Treatment Practice

With Aqumeldi® being the only licensed ACEI for use in paediatric HF (since it's launch), how has this changed your prescribing/ treatment practise?

ACEI Guidelines

Can you briefly tell us about how you developed the paediatric HF ACEI guidelines at your trust and since its implementation, how this has changed clinical practice?

Patient Cases (Part 1)

Considering the guidelines, could you share with us some patient cases regarding ACEI initiation?

Patient Cases (Part 2)

Considering the guidelines, could you share with us some patient cases regarding ACEI initiation?

Dosing Preference

Can you tell us about your clinical practice with Aqumeldi® regarding the once or twice daily dosing preference?

Feedback from Parents and Carers using Aqumeldi®

What feedback have you had from parents/ carers of children using Aqumeldi®?

A Cardiology Team Experience with Aqumeldi®

How would you describe your multidisciplinary team's experience with Aqumeldi®?

UK-ENA-26-0007 | April 2026

Adverse Event Reporting Information

UK: Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard

Republic of Ireland: Adverse events should be reported. Reporting forms and information can be found at: www.hpra.ie.

Adverse events should also be reported to Proveca Limited. Phone: +44 333 200 1866 E-Mail: medinfo@proveca.com

You are now leaving this website and will be redirected. Are you sure you wish to continue?